The AOMT is proud to have helped lead the world in education of interdisciplinary teams of clinicians and researchers worldwide on the application of Orofacial Myofunctional Therapy as an adjunct treatment of sleep breathing disorders. To date, we are engaged with over three dozen universities in the facilitation of research and curriculum development.
There has been a great deal of interest in the emerging field of orofacial myofunctional therapy (OMT) as an adjunct therapy in an allied approach for the treatment of OSA and snoring.
The newest editions of Kryger’s & Dement’s Principles and Practice of Sleep Medicine as well as Sheldon’s and Gozal’s Principles and Practice of Pediatric Sleep Medicine both include chapters on myofunctional therapy. The journal SLEEP last year published a “Myofunctional Therapy to Treat OSA: Meta-Analysis and Review” that concluded that “myofunctional therapy decreases apnea-hypopnea index by approximately 50% in adults and 62% in children” with relative increases in oxygen saturation (Camacho et al, 2015). Keynote addresses at the WASM World Congress on Sleep Medicine and the IPSA International Pediatric Sleep Congress have singled out myofunctional therapy for its efficacy and promise.